DHRDANAHER CORP /DE/

NYSE danaher.com


$ 251.21 $ 1.66 (0.67 %)    

Thursday, 09-May-2024 15:54:10 EDT
QQQ $ 440.94 $ 0.48 (0.11 %)
DIA $ 394.11 $ 4.00 (1.03 %)
SPY $ 520.10 $ 2.65 (0.51 %)
TLT $ 90.64 $ 0.60 (0.67 %)
GLD $ 216.86 $ 2.16 (1.01 %)
$ 249.55
$ 249.32
$ 0.00 x 0
$ 0.00 x 0
$ 249.06 - $ 251.36
$ 181.70 - $ 258.72
1,471,346
na
186.81B
$ 0.88
$ 42.44
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-22-2024 03-29-2024 10-Q
2 02-21-2024 12-31-2023 10-K
3 10-23-2023 09-29-2023 10-Q
4 07-24-2023 06-30-2023 10-Q
5 04-25-2023 03-31-2023 10-Q
6 02-22-2023 12-31-2022 10-K
7 10-19-2022 09-30-2022 10-Q
8 07-20-2022 07-01-2022 10-Q
9 04-20-2022 04-01-2022 10-Q
10 02-23-2022 12-31-2021 10-K
11 10-20-2021 10-01-2021 10-Q
12 07-21-2021 07-02-2021 10-Q
13 04-22-2021 04-02-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 10-22-2020 10-02-2020 10-Q
16 07-23-2020 07-03-2020 10-Q
17 05-06-2020 04-03-2020 10-Q
18 02-21-2020 12-31-2019 10-K
19 10-24-2019 09-27-2019 10-Q
20 07-18-2019 06-28-2019 10-Q
21 04-18-2019 03-29-2019 10-Q
22 02-21-2019 12-31-2018 10-K
23 10-18-2018 09-28-2018 10-Q
24 07-19-2018 06-29-2018 10-Q
25 04-19-2018 03-30-2018 10-Q
26 02-21-2018 12-31-2017 10-K
27 10-19-2017 09-29-2017 10-Q
28 07-20-2017 06-30-2017 10-Q
29 04-20-2017 03-31-2017 10-Q
30 02-22-2017 12-31-2016 10-K
31 10-20-2016 09-30-2016 10-Q
32 07-25-2016 07-01-2016 10-Q
33 04-21-2016 04-01-2016 10-Q
34 02-24-2016 12-31-2015 10-K
35 10-22-2015 10-02-2015 10-Q
36 07-23-2015 07-03-2015 10-Q
37 04-23-2015 04-03-2015 10-Q
38 02-25-2015 12-31-2014 10-K
39 10-16-2014 09-26-2014 10-Q
40 07-17-2014 06-27-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 danaher-launches-collaboration-with-johns-hopkins-university-aiming-to-improve-neurological-diagnosis

The Danaher Beacon for Brain Injury Diagnostics seeks to identify mild Traumatic Brain Injury (TBI) earlier and more precisel...

 citigroup-maintains-buy-on-danaher-raises-price-target-to-290

Citigroup analyst Patrick Donnelly maintains Danaher (NYSE:DHR) with a Buy and raises the price target from $280 to $290.

 td-cowen-maintains-buy-on-danaher-raises-price-target-to-290

TD Cowen analyst Dan Brennan maintains Danaher (NYSE:DHR) with a Buy and raises the price target from $280 to $290.

 b-of-a-securities-maintains-neutral-on-danaher-raises-price-target-to-270

B of A Securities analyst Derik De Bruin maintains Danaher (NYSE:DHR) with a Neutral and raises the price target from $258 t...

 barclays-maintains-equal-weight-on-danaher-raises-price-target-to-270

Barclays analyst Luke Sergott maintains Danaher (NYSE:DHR) with a Equal-Weight and raises the price target from $260 to $270.

 baird-maintains-outperform-on-danaher-raises-price-target-to-271

Baird analyst Catherine Schulte maintains Danaher (NYSE:DHR) with a Outperform and raises the price target from $259 to $271.

 stocks-rally-on-weaker-pmi-data-tech-earnings-optimism-dollar-falls-whats-driving-markets-tuesday

Stocks surged as weak economic data raised hopes for Fed rate cut. S&P 500 up 1.2%, Nasdaq 100 up 1.5%, Dow Jones up 0.6%. ...

 why-is-life-science-focused-danaher-trading-higher-on-tuesday

Danaher Corp's Q1 sales beat expectations despite a Y/Y decrease. Rainer Blair, CEO, highlights strong revenue, earnings, a...

 earnings-scheduled-for-april-23-2024

Companies Reporting Before The Bell • RTX (NYSE:RTX) is expected to report quarterly earnings at $1.23 per share on revenue of...

 danaher-q1-2024-adj-eps-192-beats-171-estimate-sales-5796b-beat-5622b-estimate

Danaher (NYSE:DHR) reported quarterly earnings of $1.92 per share which beat the analyst consensus estimate of $1.71 by 12.28 p...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION